Involvement of cannabinoid CB1 receptors in drug addiction:: effects of rimonabant on behavioral responses induced by cocaine

被引:0
|
作者
Filip, Malgorzata
Golda, Anna
Zaniewska, Magdalena
McCreary, Andrew C.
Nowak, Ewa
Kolasiewicz, Waclaw
Przegalinski, Edmund
机构
[1] Polish Acad Sci, Inst Pharmacol, PL-31343 Krakow, Poland
[2] Solvay Pharmaceut Res, Weesp, Netherlands
关键词
cannabinoid CB1 receptors; cocaine; drug addiction; rimonabant;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A lot of evidence indicate that endocannabinoids and cannabinoid CB1 receptors are implicated in drug addiction. In the present study, we investigated the effect of the cannabinoid CB1 receptor antagonist/partial agonist rimonabant on the cocaine-maintained reinforcement and relapse to cocaine seeking as well as on the cocaine challenge-induced hyperactivity in sensitized rats and on discriminative stimulus effects of cocaine in rats. We found that endocannabinoids were not involved in maintenance of cocaine reinforcement and its subjective effects since pharmacological blockade of cannabinoid CB1 receptors altered neither self-administration nor discriminative stimulus effects of cocaine. On the other hand, withdrawal from repeated access or exposure to cocaine and then a reinstatement of cocaine-seeking behavior or a sensitized locomotor response to a single cocaine challenge, respectively, was potently reduced by pretreatment with rimonabant. The latter observations may show that repeated cocaine treatment and the drug withdrawal produce-apart from behavioral effects-also different neural consequences in the endocannabinoid systems in rats.
引用
收藏
页码:806 / 819
页数:14
相关论文
共 50 条
  • [1] Involvement of CB1 cannabinoid receptors in emotional behaviour
    Miquel Martin
    Catherine Ledent
    Marc Parmentier
    Rafael Maldonado
    Olga Valverde
    Psychopharmacology, 2002, 159 : 379 - 387
  • [2] Involvement of CB1 cannabinoid receptors in emotional behaviour
    Martin, M
    Ledent, C
    Parmentier, M
    Maldonado, R
    Valverde, O
    PSYCHOPHARMACOLOGY, 2002, 159 (04) : 379 - 387
  • [3] Update on rimonabant - A selective cannabinoid CB1 antagonist
    Boyd, ST
    Fremming, BA
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 994 - 994
  • [4] The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
    Lopes, Jadna B.
    Bastos, Juliana R.
    Costa, Rayssa B.
    Aguiar, Daniele C.
    Moreira, Fabricio A.
    PSYCHOPHARMACOLOGY, 2020, 237 (02) : 385 - 394
  • [5] The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
    Jadna B. Lopes
    Juliana R. Bastos
    Rayssa B. Costa
    Daniele C. Aguiar
    Fabrício A. Moreira
    Psychopharmacology, 2020, 237 : 385 - 394
  • [6] Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine
    Gobira, Pedro H.
    Oliveira, Ana C.
    Gomes, Julia S.
    da Silveira, Vivian T.
    Asth, Laila
    Bastos, Juliana R.
    Batista, Edleusa M.
    Issy, Ana C.
    Okine, Bright N.
    de Oliveira, Antonio C.
    Ribeiro, Fabiola M.
    Del Bel, Elaine A.
    Aguiar, Daniele C.
    Finn, David P.
    Moreira, Fabricio A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (10) : 1541 - 1551
  • [7] Blockade of CB1 cannabinoid receptors and activation of CB2 interact to prevent cocaine-responses
    Gobira, P.
    Moreira, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S263 - S264
  • [8] Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone
    Elmas, Pinar
    Ulugol, Ahmet
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (11) : 1533 - 1538
  • [9] Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone
    Pinar Elmas
    Ahmet Ulugol
    Journal of Neural Transmission, 2013, 120 : 1533 - 1538
  • [10] Context-specific reversal of cocaine Sensitization by the CB1 cannabinoid receptor antagonist rimonabant
    Gerdeman, Gregory L.
    Schechter, Jason B.
    French, Edward D.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (11) : 2747 - 2759